Introduction The extensive heterogeneity of prostate cancer (PCa) and multilayered
complexity of progression to castration-resistant prostate cancer (CRPC) have contributed to …

Simple Summary The mainstay of treatment for advanced prostate cancer (PCa) is androgen
deprivation therapy (ADT), and although patients initially respond, almost all will eventually …

Background Patient outcomes were assessed based on a pre-biopsy ExoDx Prostate (EPI)
score at 2.5 years of the 5-year follow-up of ongoing prostate biopsy Decision Impact Trial of …

Simple Summary Prostate-specific membrane antigen (PSMA) is a promising target for both
imaging and radioligand therapies (RLT) for men with prostate cancer. However, not all …

Prostate cancer (PCa) is the most frequent malignancy in male urogenital system around
worldwide. We performed molecular subtyping and prognostic assessment based on …

Purpose To explore the preponderant diagnostic performances of IVIM and DKI in predicting
the Gleason score (GS) of prostate cancer. Methods Diffusion-weighted imaging data were …

Background Prostate-specific antigen (PSA) is commonly used as a serum biomarker for the
detection of prostate cancer. However, levels of PSA in serum do not reliably distinguish …

Histopathology is considered the gold standard in determining the presence and nature of
tumors. Technological advances in automated high-speed and high-resolution wholeslide …

Gene rearrangement is reported to be associated to the aggressive phenotype and poor
prognosis in prostate cancer. We identified a gene fusion between a transcription repressor …

Background Synthetic magnetic resonance imaging (SyMRI) is a fast, standardized, and
robust novel quantitative technique that has the potential to circumvent the subjectivity of …